Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04551482 · ClinicalTrials.gov registry record · Phase 2
Oxytocin for Weight Loss in Adolescents
A Phase 2 study of Obesity, Adolescent and Oxytocin, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT04551482 is a Phase 2 study of Obesity, Adolescent and Oxytocin that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 75 participants, below the 231-participant average among 6 other Obesity, Adolescent trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04551482, a Phase 2 study of Obesity, Adolescent and Oxytocin, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, double blind, placebo-controlled study of the effects of intranasal oxytocin in youths with obesity, ages 12-18 years old. Subjects will be randomized to receive intranasal oxytocin or placebo (1 spray per nostril, 4 times per day) for 12 weeks. Study visits include screening to determine eligibility, 2-part main study visits at baseline, week 8, and week 12, and safety check-in visits at weeks 1, and 4; phone calls at weeks 2, 6, and 10, with a safety follow-up visit 6 weeks after the last dose of study drug. Study procedures include appetite, behavioral, metabolic, and endocrine assessments.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Oxytocin nasal spray
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2021-07-28 |
| Est. Completion | 2027-03-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04551482
The ClinicalTrials.gov registry entry for NCT04551482 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 231-participant average among 6 other Obesity, Adolescent trials with a reported enrollment target (68% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obesity, Adolescent appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04551482 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04551482 about?
NCT04551482 is a clinical study titled "Oxytocin for Weight Loss in Adolescents". This is a randomized, double blind, placebo-controlled study of the effects of intranasal oxytocin in youths with obesity, ages 12-18 years old. Subjects will be randomized to receive intranasal oxytocin or placebo (1 spray per nostril, 4 times per day) for 12 weeks. Study visits include screening t...
What is the current status of trial NCT04551482?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2021-07-28. Estimated completion is 2027-03-31.
What conditions does trial NCT04551482 study?
This clinical trial studies the following conditions: Obesity, Adolescent, Oxytocin.
What interventions are being tested in trial NCT04551482?
The interventions under investigation include: Placebo (DRUG), Oxytocin nasal spray (DRUG).
Who is sponsoring clinical trial NCT04551482?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04551482 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity, Adolescent
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pain and Weight Treatment: Development and Trial of PAW
RECRUITING · NA
-
Wakaya: Rising Up for Choctaw Youth Health
RECRUITING · NA
-
A Sensory Strategy to Cut Sugary Beverages in African/American and Latine Adolescents
RECRUITING · NA
-
Health Without Barriers/Salud Sin Barreras- Northern Colorado
RECRUITING · NA
-
Guys/Girls Opt for Activities for Life Trial (GOAL) to Increase Young Adolescents' Physical Activity and Healthy Eating
ACTIVE NOT RECRUITING · NA
-
Managing AsThma AnD Obesity Related Symptoms (MATADORS) Feasibility Study
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.